Clinical trials in Mayen

Innovative research focusing on chronic lymphocytic leukemia (CLL) treatments, particularly evaluating new therapeutic combinations for previously untreated patients. Studies examine various treatment approaches including targeted therapies and novel drug combinations.

• Treatment-naive CLL patients
• High-risk CLL variants
• Novel drug combinations

Trials aim to improve progression-free survival through optimized treatment strategies.

Comprehensive studies investigating treatments for HER2-negative breast cancer, including advanced and metastatic forms. Research encompasses both early-stage interventions and advanced disease management.

• HR-positive metastatic breast cancer
• Novel therapeutic combinations
• Treatment resistance patterns

Investigations focus on improving survival outcomes and developing targeted treatment approaches.

Clinical research examining therapeutic options for functional gastrointestinal disorders. Studies evaluate natural compounds and their impact on digestive health and quality of life.

• Gut permeability assessment
• Symptom management
• Quality of life improvements

Research aims to enhance understanding of treatment efficacy and patient outcomes.